glp 1 drugs for alcohol GLP-1 receptor agonists the treatment of use disorder GLP-1s Hold Promise as Treatment

Efficacy and safety of once-weekly semaglutide versus once-daily sitagliptin as an add-on to metformin, thiazolidinediones, or both, in patients with type 2 diabetes (SUSTAIN 2): A 56-week, double-blind, phase 3a, randomised trial

J Mol Med (Berl) 2004;82(8):510529

En anden praktisk del af hverdagen er hndteringen af adgang

Statistics Statistical analysis was performed using SPSS 26.0 (SPSS Inc, Chicago, IL, USA)

doi: 10.1016/j.phrs.2018.03.004 39 LiljedahlL.PedersenM

2022 The major difference between these agents lies in canagliflozin, which is less selective for SGLT2 over SGLT1 and is metabolized primarily in the liver (compared to kidneys), and sotagliflozin, which inhibits both SGLT1 and SGLT2